Anthony Stano

Anthony Stano has an extensive work experience in the pharmaceutical industry. Anthony currently works as a Key Account Manager at Braeburn, starting in July 2023. Prior to that, they worked as a Rare disease account manager at Mallinckrodt Pharmaceuticals from March 2022 to November 2022. Before that, they served as a Business Account Executive-Ultra Rare Disease at Alnylam Pharmaceuticals from January 2020 to March 2022. From October 2015 to January 2020, they held the position of Territory Business Manager (Rare Disease) at Intercept Pharmaceuticals and was recognized as the 2019 presidents club winner. At AbbVie, they served as an HCV sales specialist from January 2014 to October 2015. Anthony also had the role of Hospital Account Manager at Otsuka America Pharmaceutical, Inc. from May 2010 to October 2013. In the earlier stages of their career, they worked as a Critical Care Business Manager at The Medicine's Company from August 2007 to May 2010, as a Senior Sales Rep/Hospital Sales at Sepracor from September 2005 to August 2007, as a Specialy Sales Rep at Novartis from July 2002 to September 2005, and as a Sales representative at Janssen Inc. from April 2001 to July 2002.

Anthony Stano pursued their undergraduate studies from 1994 to 1998 at the University of Massachusetts, Amherst. During this time, they obtained a Bachelor of Science degree in Environmental Science.